FDA Warns Lancome For Gene/Stem-Cell Claims: A Signal To Marketplace?
This article was originally published in The Tan Sheet
Claims for L’Oreal’s Lancome brand’s Genifique anti-aging line identify the products as drugs, FDA says. The agency cites claims that the brand’s technology “boosts the activity of genes” and “has been shown to improve the condition” around stem cells – language not unique in the anti-aging cosmeceutical market.
You may also be interested in...
Following allegations from short seller Citron Research that it operates a “pyramid compensation scheme” in China, Nu Skin gives investors a peek into its business model. The firm recorded sales growth of 40% in its second quarter, driven by a 152% jump in China, and “the best is yet to come,” Nu Skin says.
Mibelle’s R&D team has been working to expand the company’s actives portfolio and capitalize on the popularity of plant stem cells that can fend off the signs of aging.
More anti-aging solutions are reaching market with claims to stimulate stem cells in skin and protect or even repair DNA. Makucell, E’shee and Terraternal add new offerings to the mix.